• Explore /
  • Poster
  • / CANOPY-A: A phase III, multicenter, randomized, double-blind, placebo-controlled trial evaluating canakinumab as adjuvant therapy in patients (pts) with completely resected non-small cell lung cancer (NSCLC).

CANOPY-A: A phase III, multicenter, randomized, double-blind, placebo-controlled trial evaluating canakinumab as adjuvant therapy in patients (pts) with completely resected non-small cell lung cancer (NSCLC).

Abstract Video & Slides Poster

Authors

null

Edward B. Garon

David Geffen School of Medicine, University of California/TRIO-US Network, Los Angeles, CA

Edward B. Garon , Andrea Ardizzoni , Fabrice Barlesi , Byoung Chul Cho , Pedro De Marchi , Yasushi Goto , Dariusz M. Kowalski , Shun Lu , Luis G. Paz-Ares , David R. Spigel , Alexander I. Spira , Michael Thomas , Mimi Leung , Jason Baum , Zewen Zhu , Maria do Socorro Oliveira Portella , James Chih-Hsin Yang

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2020 ASCO Virtual Scientific Program

Session Type

Poster Session

Session Title

Lung Cancer—Non-Small Cell Local-Regional/Small Cell/Other Thoracic Cancers

Track

Lung Cancer

Sub Track

Adjuvant Therapy

Clinical Trial Registration Number

NCT03447769

Citation

J Clin Oncol 38: 2020 (suppl; abstr TPS9075)

DOI

10.1200/JCO.2020.38.15_suppl.TPS9075

Abstract #

TPS9075

Poster Bd #

268

Abstract Disclosures

Similar Posters

First Author: Yuming Zhu

First Author: Siamak Daneshmand

First Author: Sumanta K. Pal

First Author: Edward B. Garon